Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.451NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.313NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.402NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.609NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.344NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.556NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.245NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.403NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.636NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.126NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.47NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDQ.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JD.1.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBC.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FY.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.31.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GK.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.27NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.2.3.17NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FD.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.44NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.26NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GN.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FW.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FY.1.2.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.525NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.480NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.214NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.304NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.214.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.577NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.639NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
A.2.5.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AZ.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.270NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.227NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
U.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.36.28NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.15NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.24NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.236NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.153NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.302NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.194NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.55NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.51NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.308NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.138NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.379NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used